https://www.selleckchem.com/pr....oducts/sch-900776.ht
There is a mounting crisis in treatment of bacterial diseases. The appearance of nosocomial infections produced by multi-drug resistant bacteria is rapidly increasing and at the same time the pharmaceutical industry has been abandoning new antibiotic discovery. To help understand why, we investigated the decision-making processes behind three novel antibiotics that were initially discovered in the late 1980's and early 1990's daptomycin, linezolid, and lysobactin. Each antibiotic was investigated by two highly qualified scientific or
Like
Comment
Share
